Clinical Trial Update: Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Paclitaxel, nab-paclitaxel, or ixabepilone with or without bevacizumab in stage IIIC or stage IV breast cancer has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Ixabepilone (ixabepilone)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)
• others

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Estrogen Receptor Negative, Estrogen Receptor Positive | Phase 3 | Status: COMPLETED | Results posted: 2015-07-02